Phoenix Biotech Acquisiti...

NASDAQ: PBAX · Real-Time Price · USD
5.85
0.37 (6.75%)
At close: Feb 14, 2024, 9:56 PM

Phoenix Biotech Acquisition Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a 254.83K n/a
Operating Income
-16.2M -2.91K -332.03K
Interest Income
n/a 2.84M n/a
Pretax Income
-11.09M -68.58K -332.42K
Net Income
-11.09M -667.74K -315.55K
Selling & General & Admin
9.12M 2.84M 251.71K
Research & Development
7.08M n/a n/a
Other Expenses
n/a 64.05K -80.32K
Operating Expenses
16.2M 2.91M 332.03K
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 251.27K
Cost & Expenses
n/a 2.91M 332.03K
Income Tax Expense
n/a 599.16K -16.87K
Shares Outstanding (Basic)
49.68M 67.48M 68.94M
Shares Outstanding (Diluted)
49.68M 67.48M 68.94M
EPS (Basic)
-0.22 -0.01 -0.00
EPS (Diluted)
-0.22 -0.01 -0.00
EBITDA
-16.2M -5.74M -332.03K
EBIT
n/a n/a n/a
Depreciation & Amortization
n/a -5.67M 236.56K